3Xiang YJ,Dai SM.Prevalence of rheumatic diseases and disability in China.Rheumatol Int 2009; 29:481-490.
4Vitali C,Bombardieri S,Jonsson R,Moutsopoulos HM,Alexander EL,Carsons SE,et al.Classication criteria for sj(o)gren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group.Ann Rheum Dis 2002; 61:554-558.
5Zhao Y,Dong Y,Guo XP,Tang FL.Clinical analysis of primary Sj(o)gren's syndrome.Beijing Med (Chin) 1997; 19:100-104.
6García-Carrasco M,Ramos-Casals M,Rosas J,Pallarés L,Calvo-Alen J,Cervera R,et al.Primary sj(o)gren syndrome:clinical and immunologic disease patterns in a cohort of 400patients.Medicine (Baltimore) 2002; 81:270-280.
7Skopouli FN,Dafni U,Ioannidis JP,Moutsopoulos HM.Clinical evolution,and morbidity and mortality of primary sj(o)gren's syndrome.Semin Arthritis Rheum 2000; 29:296-304.
8Davidson BKS,Kelly CA,Griffiths ID.Primary sj(o)gren's syndrome in the North East of England:a long-term follow-up study.Rheumatology 1999; 38:245-253.
9Alamanos Y,Tsifetaki N,Voulgari PV,Venetsanopoulou AI,Siozos C,Drosos AA.Epidemiology of primary Sjogren's syndrome in north-west Greece,1982-2003.Rheumatology 2006; 45:187-191.
10Ramos-Casals M,Brito-Zeron P,Yague J,Akasbi M,Bantista R,Ruano M,et al.Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sj(o)gren's syndrome.Rheumatology 2005; 44:89-94.
